References
- Jabbour E, Cortes J, Kantarjian H. Treatment selection after imatinib resistance in chronic myeloid leukemia. Target Oncol 2009;4:3–10.
- Hadden JW. Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol 2003;3:1061–71.
- Costello RT, Rey J, Fauriat C, Gastaut JA, Olive D. New approaches in the immunotherapy of haematological malignancies. Eur J Haematol 2003;70:333–45.
- Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176–81.
- Sensi M, Parmiani G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune response. Immunol Today 1995;16:588–95.
- Lozeron P, Chabas D, Duprey B, Lyon-Caen O, Liblau R. T cell receptor V beta 5 and V beta 17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients. Mult Scler 1998;4:154–61.
- Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994;153:2807–18.
- Li Y. Leukemia associated clonal expansion TCR Vβ subfamily T cells. Hematology 2003;8:375–84.
- Li Y, Yang L, Chen S, Zhang Y, Wu X. The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen. Hematology 2005;10:387–92.
- Rezvany M, Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H. Oligoclonal TCR BV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood 1999;94:1063–9.
- Rezvany MR, Jeddi-Tehrani M, Wigzell H, Osterborg A, Mellstedt H. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia. Blood 2003;101:1063–70.
- thor Straten P, Guldberg P, Gronbeak K, Hansen MR, Kirkin AF, Seremet T, et al.. In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonatypes. J Immunol 1999;163:443–7.
- Mami-Chouaib F, Echchakir H, Dorothée G, Vergnon I, Chouaib S. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen. Immunol Rev 2002;188:114–21.
- Geng SX, Li YQ, Chen SH, Yang LJ, Yin QS, Wu XL, et al.. Peripheral blood naive T cell level and its T cell receptor Vbeta repertoire usage profile in patients with chronic myelogenous leukemia.Zhonghua Xue Ye Xue Za Zhi 2005;26:413–6(Chinese).
- Li Y, Chen S, Yang L, Yin Q, Geng S, Wu X, et al.. TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T cells. Transplant Immunol 2007;18:151–8.
- Gorski J, Yassai M, Zhu X, Kissela B, Kissella B. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. J Immunol 1994;152:5109–19.
- Assaf C, Hummel M, Dippel E, Goerdt S, Muller HH, Anagnostopoulos I, et al.. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000;96:640–6.
- Farace F, Orlanducci F, Dietrich PY, Gaudin C, Angevin E, Courtier MH, et al.. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J Immunol 1994;153:4281–90.
- Coleman S, Perera P, Fisher J, Hoy T, Burnett AK, Lim SH. Abnormal TCR V beta repertoire in patients with chronic myeloid leukaemia. Br J Haematol 1995;90:358–63.
- Serrano D, Monteiro J, Allen SL, Kolitz J, Schulman P, Lichtman SM, et al.. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol 1997;158:1482–9.
- Kluin-Nelemans JC, Kester MG, Melenhorst JJ, Landegent JE, van de Corput L, Willemze R, et al.. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996;87:3795–802.
- Alatrakchi N, Farace F, Frau E, Carde P, Munck JN, Triebel F. T-cell clonal expansion in patients with B-cell lymphoproliferative disorders. J Immunother 1998;21:363–70.
- Li YQ, Yang LJ, Chen SH, Zhang YP, Zhang XL, Luo GX. TCR Vβ repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia. Chin Med J 2004;117:840–3.
- Brown RD, Yuen E, Nelson M, Gibson J, Joshua D. The prognostic significance of T cell receptor beta gene rearrangements and idotype-reactive T cells in multiple myeloma. Leukemia 1997;11:1312–7.